R97
⚠ Non-billable
Abnormal tumor markers
ICD-10-CM · FY2026 · Symptoms, Signs and Abnormal Clinical and Laboratory Findings
Code
R97
System
ICD-10-CM
Billable
No — use specific code
Effective
FY2026
Chapter
Symptoms, Signs and Abnormal Clinical and Laboratory Findings
Source
CMS / CDC NCHS
⚠ Verify before billing. Confirm against the current CMS/NCHS ICD-10-CM files and your payer's rules before claims submission.
Frequently asked questions
What is ICD-10 code R97?
ICD-10-CM code R97 represents Abnormal tumor markers. It is a non-billable header code requiring a more specific subcategory in the Symptoms, Signs and Abnormal Clinical and Laboratory Findings chapter, effective October 1, 2025 – September 30, 2026.
Is R97 billable?
No. R97 is a non-billable header. Select a more specific subcategory for claims submission.
What chapter is R97 in?
R97 belongs to the Symptoms, Signs and Abnormal Clinical and Laboratory Findings chapter (R00–R99) of ICD-10-CM.
Related codes in the R97 category
R97.0
Elevated carcinoembryonic antigen [CEA]
Billable
R97.1
Elevated cancer antigen 125 [CA 125]
Billable
R97.2
Elevated prostate specific antigen [PSA]
Non-billable
R97.8
Other abnormal tumor markers
Billable
R97.20
Elevated prostate specific antigen [PSA]
Billable
R97.21
Rising PSA following treatment for malignant neoplasm of prostate
Billable
Search all 98,186 ICD-10-CM codes instantly
Search ICDwise →